A novel protein, p27SJ, extracted from a callus culture of the St. Johns wort plant (Hypericum perforatum) suppresses HIV-1 expression and inhibits its replication, according to researchers at Temple University School of Medicines department of neuroscience and Center for Neurovirology (CNV).
Their findings, p27SJ, a novel protein in St. Johns wort, that suppresses expression of HIV-1 genome, will be published online in the Oct. 27 issue of Gene Therapy. Kamel Khalili, PhD, director of CNV, professor, and acting chair of Temples department of neuroscience, and the studys lead author, said the researchers were originally examining plant extracts from St. Johns wort cultured in the laboratory to see if they had any effect on cell growth or the behavior of brain cells in vitro.
During the course of that study, we also looked to see whether these plant extracts that we had isolated from the callus culture had any anti-viral activity, said Khalili. We soon discovered that the plant extract inhibited HIV-1 gene expression and replication in infected cells.
Next, the team sought to isolate the protein from the plant extract responsible for the observed anti-viral activity. After identifying the protein, the group cloned the gene, which they realized was a novel protein and named p27SJ.
It has unique characteristics, said Khalili. Remember, it is a plant protein, and so far, to my knowledge, there is no similar protein to that in mammalian cells.
After cloning the gene, the researchers then were able to identify the molecular mechanism by which the protein is able to suppress HIV-1 gene expression and replication, according to Khalili.
It is the expression of the viral gene and the replication of the viral genome that leads to the development of AIDS in HIV-infected individuals.
Our studies indicate that p27SJ has the capacity to inhibit expression of the HIV-1 gene by interacting with both cellular proteins and viral proteins, said Khalili. Since HIV-1 gene expression relies heavily on these factors, p27SJ can block viral replication by interfering with the proteins recruited by HIV-1 to increase viral gene expression.
Although St. Johns wort is a popular herb that can be purchased as a dietary supplement over the counter in health food stores, neighborhood pharmacies and supermarkets, the Temple researchers did not use the supplement as a source for St. Johns wort during the study. As a supplement, St Johns wort is often taken as an anti-depressant, although the Food and Drug Administration has not approved it as such, so manufacturers cannot advertise it as a depression treatment nor can doctors prescribe it.
Khalili strongly emphasized that the researchers do not know if the p27SJ protein they discovered is present in the St. Johns wort preparations sold as a dietary supplement, and therefore, those tablets should not be considered as a treatment for patients infected with HIV-1.
We dont know yet how we have to deliver the protein to cells infected with HIV-1, he said. Even if the protein were present in the tablets, we dont know how much might be present and whether the protein would be effective when ingested.
The study, which was partially funded through grants from the National Institutes of Health, was done in collaboration with Yerevan State University in Armenia. Khalilis co-investigators included Nune Darbinian-Sarkissian, Armine Darbinyan, Jessica Otte, Sujatha Radhakrishnan, Bassel E. Sawaya, Alla Arzumanyan, Galina Chipitsyna, Jay Rappaport and Shoreh Amini from Temples CNV, and Yuri Popov, an internationally respected plant biologist from Yerevan State University.
Source Temple University
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.